EGFR and adenocarcinoma: It has also been shown that female sex, never having smoked, Asian ethnicity and adenocarcinoma histology could be predictors of a better response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) therapy [2,3,4].